22 research outputs found
Somatotypes trajectories during adulthood and their association with COPD phenotypes
Rationale: Chronic obstructive pulmonary disease (COPD) comprises distinct phenotypes, all characterised by airflow limitation.
Objectives: We hypothesised that somatotype changes - as a surrogate of adiposity - from early adulthood follow different trajectories to reach distinct phenotypes.
Methods: Using the validated Stunkard''s Pictogram, 356 COPD patients chose the somatotype that best reflects their current body build and those at ages 18, 30, 40 and 50 years. An unbiased group-based trajectory modelling was used to determine somatotype trajectories. We then compared the current COPD-related clinical and phenotypic characteristics of subjects belonging to each trajectory.
Measurements and main results: At 18 years of age, 88% of the participants described having a lean or medium somatotype (estimated body mass index (BMI) between 19 and 23 kg.m(-2)) while the other 12% a heavier somatotype (estimated BMI between 25 and 27 kg.m(-2)). From age 18 onwards, five distinct trajectories were observed. Four of them demonstrating a continuous increase in adiposity throughout adulthood with the exception of one, where the initial increase was followed by loss of adiposity after age 40. Patients with this trajectory were primarily females with low BMI and D-LCO (diffusing capacity of the lung for carbon monoxide). A persistently lean trajectory was seen in 14% of the cohort. This group had significantly lower forced expiratory volume in 1 s (FEV1), D-LCO, more emphysema and a worse BODE (BMI, airflow obstruction, dyspnoea and exercise capacity) score thus resembling the multiple organ loss of tissue (MOLT) phenotype.
Conclusions: COPD patients have distinct somatotype trajectories throughout adulthood. Those with the MOLT phenotype maintain a lean trajectory throughout life. Smoking subjects with this lean phenotype in early adulthood deserve particular attention as they seem to develop more severe COPD
Somatotypes trajectories during adulthood and their association with COPD phenotypes
Rationale: Chronic obstructive pulmonary disease (COPD) comprises distinct phenotypes, all
characterised by airflow limitation.
Objectives: We hypothesised that somatotype changes â as a surrogate of adiposity â from early adulthood
follow different trajectories to reach distinct phenotypes.
Methods: Using the validated Stunkardâs Pictogram, 356 COPD patients chose the somatotype that best
reflects their current body build and those at ages 18, 30, 40 and 50 years. An unbiased group-based
trajectory modelling was used to determine somatotype trajectories. We then compared the current
COPD-related clinical and phenotypic characteristics of subjects belonging to each trajectory.
Measurements and main results: At 18 years of age, 88% of the participants described having a lean or
medium somatotype (estimated body mass index (BMI) between 19 and 23 kg·mâ2
) while the other 12% a
heavier somatotype (estimated BMI between 25 and 27 kg·mâ2
). From age 18 onwards, five distinct
trajectories were observed. Four of them demonstrating a continuous increase in adiposity throughout
adulthood with the exception of one, where the initial increase was followed by loss of adiposity after age
40. Patients with this trajectory were primarily females with low BMI and DLCO (diffusing capacity of the
lung for carbon monoxide). A persistently lean trajectory was seen in 14% of the cohort. This group had
significantly lower forced expiratory volume in 1 s (FEV1), DLCO, more emphysema and a worse BODE
(BMI, airflow obstruction, dyspnoea and exercise capacity) score thus resembling the multiple organ loss
of tissue (MOLT) phenotype.
Conclusions: COPD patients have distinct somatotype trajectories throughout adulthood. Those with the
MOLT phenotype maintain a lean trajectory throughout life. Smoking subjects with this lean phenotype in
early adulthood deserve particular attention as they seem to develop more severe COPD
Determination of gamma and-2 beta(s) from charmless two-body decays of beauty mesons
Using the latest LHCb measurements of time-dependent CP violation in the
B^0_s -> K^+K^- decay, a U-spin relation between the decay amplitudes of B^0_s
-> K^+K^- and B^0 -> \pi^+\pi^- decay processes allows constraints to be placed
on the angle gamma of the unitarity triangle and on the B^0_s mixing phase
-2\beta_s. Results from an extended approach, which uses additional inputs on
B^0 -> \pi^0\pi^0 and B^+ -> \pi^+\pi^0 decays from other experiments and
exploits isospin symmetry, are also presented. The dependence of the results on
the maximum allowed amount of U-spin breaking is studied. At 68% probability,
the value \gamma = ( 63.5 +7.2 -6.7 ) degrees modulo 180 degrees is determined.
In an alternative analysis, the value -2\beta_s = -0.12 +0.14 -0.16 rad is
found. In both measurements, the uncertainties due to U-spin breaking effects
up to 50% are included.Comment: updated to v2 with minor changes after journal revie
Search for CP violation in and decays
A search for \CP violation in Cabibbo-suppressed and decays is performed using collision data, corresponding to an integrated luminosity of 3~fb, recorded by the LHCb experiment. The individual -violating asymmetries are measured to be \begin{eqnarray*} \mathcal{A}_{CP}^{D^{\pm}\rightarrow K^0_{\mathrm{S}} K^{\pm}} & = & (+0.03 \pm 0.17 \pm 0.14) \% \mathcal{A}_{CP}^{D^{\pm}_{s}\rightarrow K^0_{\mathrm{S}} \pi^{\pm}} & = & (+0.38 \pm 0.46 \pm 0.17) \%, \end{eqnarray*} assuming that violation in the Cabibbo-favoured decays is negligible. A combination of the measured asymmetries for the four decay modes and gives the sum In all cases, the first uncertainties are statistical and the second systematic. The results represent the most precise measurements of these asymmetries to date and show no evidence for CP violation
Somatotypes trajectories during adulthood and their association with COPD phenotypes
Rationale: Chronic obstructive pulmonary disease (COPD) comprises distinct phenotypes, all
characterised by airflow limitation.
Objectives: We hypothesised that somatotype changes â as a surrogate of adiposity â from early adulthood
follow different trajectories to reach distinct phenotypes.
Methods: Using the validated Stunkardâs Pictogram, 356 COPD patients chose the somatotype that best
reflects their current body build and those at ages 18, 30, 40 and 50 years. An unbiased group-based
trajectory modelling was used to determine somatotype trajectories. We then compared the current
COPD-related clinical and phenotypic characteristics of subjects belonging to each trajectory.
Measurements and main results: At 18 years of age, 88% of the participants described having a lean or
medium somatotype (estimated body mass index (BMI) between 19 and 23 kg·mâ2
) while the other 12% a
heavier somatotype (estimated BMI between 25 and 27 kg·mâ2
). From age 18 onwards, five distinct
trajectories were observed. Four of them demonstrating a continuous increase in adiposity throughout
adulthood with the exception of one, where the initial increase was followed by loss of adiposity after age
40. Patients with this trajectory were primarily females with low BMI and DLCO (diffusing capacity of the
lung for carbon monoxide). A persistently lean trajectory was seen in 14% of the cohort. This group had
significantly lower forced expiratory volume in 1 s (FEV1), DLCO, more emphysema and a worse BODE
(BMI, airflow obstruction, dyspnoea and exercise capacity) score thus resembling the multiple organ loss
of tissue (MOLT) phenotype.
Conclusions: COPD patients have distinct somatotype trajectories throughout adulthood. Those with the
MOLT phenotype maintain a lean trajectory throughout life. Smoking subjects with this lean phenotype in
early adulthood deserve particular attention as they seem to develop more severe COPD
Road map for selected key measurements from LHCb
Six of the key physics measurements that will be made by the LHCb experiment, concerning CP asymmetries and rare B decays, are discussed in detail. The "road map" towards the precision measurements is presented, including the use of control channels and other techniques to understand the performance of the detector with the first data from the LHC.Six of the key physics measurements that will be made by the LHCb experiment, concerning CP asymmetries and rare B decays, are discussed in detail. The 'road map' towards the precision measurements is presented, including the use of control channels and other techniques to understand the performance of the detector with the first data from the LHC